Plus d’un million de livres à portée de main !
Bookbot

Ernst Jucker

    Sibiriens Wälder raunen
    Antiviral agents
    Progress in Drug Research
    Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques
    Carotenoids
    • Focusing on recent advancements in drug research, this volume presents eight comprehensive reviews covering topics such as inotropic steroids, chemokines in inflammatory diseases, and the subclassification of adrenoceptors. It also explores Chinese traditional medicine, drug targets in asthma, cytokines in immunotherapy, alternative medicine, and calcium blockers in psychiatry. The collection serves as a valuable resource for both specialists and non-specialists, offering insights into the evolving landscape of pharmaceuticals and therapeutic applications.

      Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques
    • Progress in Drug Research

      • 340pages
      • 12 heures de lecture

      The book delves into the development of HIV protease inhibitors as crucial antiviral agents in the fight against AIDS, particularly in response to drug resistance to reverse transcriptase inhibitors. It highlights the synthesis and market introduction of key protease inhibitors like saquinavir, ritonavir, indinavir, and nelfinavir. The text also covers the structure-activity relationship of saquinavir and related compounds, the significance of HIV protease as a therapeutic target, and prospects for future anti-HIV drug development.

      Progress in Drug Research
    • Antiviral agents

      • 258pages
      • 10 heures de lecture

      InhaltsverzeichnisDevelopment of HIV protease inhibitors: A survey.Anti-influenza drugs and neuraminidase inhibitors.Recent advances in prevention and treatment of hepatitis C virus infections.Drug discovery and development of antiviral agents for the treatment of chronic hepatitis B virus infection.Current and potential therapies for the treatment of herpesvirus infections.Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections.

      Antiviral agents